Tevogen Bio, the company’s lead initiative, has completed a proof-of-concept clinical trial demonstrating the potential of its single-HLA–restricted, genetically unmodified allogeneic T cells. The ...
One of the most common obstacles in software teams is the tendency to translate OKRs directly into task inventories.